EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kai,Dong

第一单位： Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100000, China.

作者： Kai,Dong ^[1] ; Wenhua,Liang ^[2] ; Shen,Zhao ^[3] ; Minzhang,Guo ^[4] ; Qihua,He ^[2] ; Caichen,Li ^[3] ; Haiqing,Song ^[2] ; Jianxing,He ^[3] ; Xiaojun,Xia ^[2]

作者单位： Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100000, China. ^[1] Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China. ^[2] State Key Laboratory of Respiratory Disease & National Clinical Research Center of Respiratory Disease, Guangzhou 510120, China. ^[3] Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. ^[4]

关键词 Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)brain metastases(BM)non-small cell lung cancer (NSCLC)stereotactic radiosurgery (SRS)whole brain radiation therapy (WBRT)

DOI 10.21037/tlcr.2019.06.12

PMID 31367540

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational lung cancer research

2019年8卷3期

268-279页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

检索历史清除